×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FDMT – 4d molecular therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FDMT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/27
08:00 am
fdmt
4DMT to Participate in Upcoming Investor Conferences
Medium
Report
4DMT to Participate in Upcoming Investor Conferences
3/24
02:03 am
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
Medium
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
3/10
01:15 pm
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Bank of America Co. from $42.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Bank of America Co. from $42.00 to $40.00. They now have a "buy" rating on the stock.
3/10
08:07 am
fdmt
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD [Yahoo! Finance]
Medium
Report
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD [Yahoo! Finance]
3/10
08:00 am
fdmt
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
Medium
Report
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
3/8
01:33 am
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.
Medium
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its "sell (d-)" rating re-affirmed by analysts at Weiss Ratings.
3/6
12:29 pm
fdmt
Gene Editing Collaboration and Licensing Terms and Agreements Trends Report and Directory 2016-2024 [Yahoo! Finance]
Low
Report
Gene Editing Collaboration and Licensing Terms and Agreements Trends Report and Directory 2016-2024 [Yahoo! Finance]
3/4
08:03 am
fdmt
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Chardan Capital from $30.00 to $28.00. They now have a "buy" rating on the stock.
Medium
Report
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Chardan Capital from $30.00 to $28.00. They now have a "buy" rating on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/25
06:01 am
fdmt
Form EFFECT 4D Molecular Therapeutic
Medium
Report
Form EFFECT 4D Molecular Therapeutic
3/10
08:00 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Bizily Scott
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Bizily Scott
3/10
07:59 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kirn David
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kirn David
3/10
07:58 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Mehra Uneek
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Mehra Uneek
3/10
07:58 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kim Robert Young
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kim Robert Young
3/10
07:57 pm
fdmt
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kamal Fariborz
Low
Report
Form 4 4D Molecular Therapeutic For: Mar 06 Filed by: Kamal Fariborz
2/28
05:08 pm
fdmt
Form POS AM 4D Molecular Therapeutic
Medium
Report
Form POS AM 4D Molecular Therapeutic
2/28
04:57 pm
fdmt
Form S-8 4D Molecular Therapeutic
Medium
Report
Form S-8 4D Molecular Therapeutic
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: